NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to [...]
ICER’s Pearson, Emond Make Case for Independent Assessments
The Institute for Clinical and Economic Review's (ICER) Steven Pearson and Sarah Emond in a recent blog post outline the [...]
Dems Invite Insulin Affordability Advocates to State of the Union
A slate of Democratic legislators have invited insulin affordability activists as their guests to tonight's State of the Union address, [...]
CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
CVS Caremark's newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging [...]
PhRMA Announces HEOR Funding Opportunities
The PhRMA Foundation announced it is accepting applications for up to $100,000 in fellowships and grants for health outcomes research. [...]
FDA Pushes Back Deadline for Feedback on Drug Effectiveness Evidence Guide
The Food and Drug Administration (FDA) announced last week that it had extended the deadline for input on its draft [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
SDOH Vendors Look to Build Pathways to Key Resources
New specialized vendors are taking action with social determinants of health by developing new software solutions that aim to bridge [...]
Epic Chief Urges Hospital CEOs Oppose Proposal
Epic CEO Judy Faulkner in an email sent to hospital CEOs and presidents urged recipients to rally behind the medical [...]
Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]
JMCP Welcomes Prominent Researchers to Editorial Team
The Journal of Managed Care & Specialty Pharmacy (JMCP) is welcoming two prominent health care researchers to its editorial team [...]
CVS Releases Health Trends Report for 2020
CVS Health this week released its "Health Trends 2020" report which identifies six key trends in the health care industry, [...]
American College of Physicians Backs Medicare for All
The nation's second-largest doctors group, the American College of Physicians (ACP), is officially endorsing Medicare for All and a public [...]
New Framework Introduces New Metric in Cost-Effectiveness Analysis
A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and [...]
Concerto HealthAI Announces Funding, Partnerships at J.P. Morgan Conference
Concerto HealthAI during the J.P. Morgan Healthcare Conference announced it had secured $150 million in a new round of funding [...]
CVS, Cigna Talk M&A, Election Year
CVS and Cigna executives during the annual J.P. Morgan Healthcare Conference discussed consolidation in the insurance sector and the upcoming [...]
Dems Talk Drug Prices During Debate
Presidential hopefuls discussed ways to address high drug prices during Tuesday night's Democratic debate. According to a brief by STAT, [...]
Are FDA Approvals Less Rigorous?
A recent study suggests that legislative changes to how the Food and Drug Administration (FDA) evaluates drugs may have ultimately [...]
With $200M in Funding, Pharma Startup Wants to Bring New Drugs in ‘Sustainable Method’
With $200 million in startup funding, a new Massachusetts-based drug company called EQRx is looking to shake up the pharmaceutical [...]
Concerto HealthAI Launches New RWE Solution
Concerto HealthAI on Monday, Jan. 13, announced the launch of its new real-world evidence platform, eurekaHealth 3.0, which combines real-world [...]
Article: Stop Putting All the Blame on PBMs
Jack Kemp Foundation's Ike Brannon and DePaul University's Tony LoSasso in a recent article published on Bloomberg Law say pinning [...]
Providers’ ‘Deeply Ingrained’ Model Disrupts Shift to Value
While providers claim a number of reasons for their reluctance to shift to risk-based deals, Numerof & Associates' Rita Numerof [...]
Frakt Outlines Major Study on Health Spending
Austin Frakt in a recent article highlights some of the key findings in a study published Monday, Jan. 6, in [...]
Pharma Execs Support New Commitment to Patients
A group of pharmaceutical executives has pledged its support for a renewed effort to put the patient first after signing [...]
Evidera White Paper Highlights PPI in Europe
A recent white paper by Evidera, "Patient Preferences in Health Technology Assessment in Europe: Recent Advances and Future Potential," spotlights [...]